JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 39 No. 3 379-383
© 1998 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ng, C. K.
Right arrow Articles by McNulty, P. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ng, C. K.
Right arrow Articles by McNulty, P. H.

Effect of Hyperinsulinemia on Myocardial Fluorine-18-FDG Uptake

Chin K. Ng, Robert Soufer and Patrick H. McNulty

Yale University–VA Positron Emission Tomography Center, Section of Cardiology, VA Healthcare System, New Haven; Divisions of Nuclear Medicine and Cardiovascular Medicine, Departments of Diagnostic Radiology and Medicine, Yale University School of Medicine, New Haven, Connecticut

Correspondence: For correspondence or reprints contact: Chin K. Ng, PhD, VA Healthcare System, Positron Imaging Center (115A), 950 Campbell Ave., West Haven, CT 06516.

ABSTRACT

This study was performed to evaluate the effect of insulin on myocardial kinetics of 18F-fluorodeoxyglucose (FDG) and glucose in patients with ischemic heart disease. Methods: Twelve male patients (age range 54–79 yr; mean age 69 ± 8 yr) were studied during the fasting awake state. Patients with diabetes and previous myocardial infarction of the left anterior descending vascular bed were excluded from the study. Patients were injected with a 185-MBq (5-mCi) bolus of FDG during arterial and coronary sinus catheterization. Thirty minutes after FDG injection, paired basal arterial and coronary sinus blood samples were taken for the measurement of FDG and glucose uptake. Thereafter, a primed (100 mU · min–1 · min–2 for 10 min) continuous (50 mU · min–2 · min–1 infusion of insulin was administered for 60 min using the euglycemic clamp technique, and blood samples were repeated. Blood samples also were taken periodically for the measurement of arterial free fatty acids and insulin. Results: Euglycemic insulin infusion lowered arterial concentrations of free fatty acids, reducing myocardial extraction of free fatty acids by 85% and stimulated uptake of glucose and FDG. Myocardial glucose and FDG extraction fractions (%) increased from 1 ± 1 and 2 ± 2 at baseline to 8 ± 2 and 10 ± 3 during insulin infusion, respectively. The lumped constant value was estimated to be 1.44 ± 0.14 (r = 0.87)for the fasted state, 0.99 ± 0.07 (r = 0.74) during insulin infusion and 1.00 ± 0.05 (r = 0.92) when both groups of data were pooled together. Conclusion: The data obtained in this study show that FDG uptake quantitatively traces glucose uptake during physiological hyperinsulinemia in patients with ischemic heart disease.

Key Words: fluorine-18-fluorodeoxyglucose • insulin • lumped constant • tracer kinetics




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. Lautamaki, R. Borra, P. Iozzo, M. Komu, T. Lehtimaki, M. Salmi, S. Jalkanen, K. E. J. Airaksinen, J. Knuuti, R. Parkkola, et al.
Liver steatosis coexists with myocardial insulin resistance and coronary dysfunction in patients with type 2 diabetes
Am J Physiol Endocrinol Metab, August 1, 2006; 291(2): E282 - E290.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
R. Lautamaki, K.E. J. Airaksinen, M. Seppanen, J. Toikka, M. Luotolahti, E. Ball, R. Borra, R. Harkonen, P. Iozzo, M. Stewart, et al.
Rosiglitazone Improves Myocardial Glucose Uptake in Patients With Type 2 Diabetes and Coronary Artery Disease: A 16-Week Randomized, Double-Blind, Placebo-Controlled Study
Diabetes, September 1, 2005; 54(9): 2787 - 2794.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. D. Monti, C. Landoni, E. Setola, E. Galluccio, P. Lucotti, E. P. Sandoli, A. Origgi, G. Lucignani, P. Piatti, and F. Fazio
Myocardial insulin resistance associated with chronic hypertriglyceridemia and increased FFA levels in Type 2 diabetic patients
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1225 - H1231.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Z.-X. He, R.-F. Shi, Y.-J. Wu, Y.-Q. Tian, X.-J. Liu, S.-W. Wang, R. Shen, X.-W. Qin, R.-L. Gao, J. Narula, et al.
Direct Imaging of Exercise-Induced Myocardial Ischemia With Fluorine-18-Labeled Deoxyglucose and Tc-99m-Sestamibi in Coronary Artery Disease
Circulation, September 9, 2003; 108(10): 1208 - 1213.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Iozzo, P. Chareonthaitawee, D. Dutka, D. J. Betteridge, E. Ferrannini, and P. G. Camici
Independent Association of Type 2 Diabetes and Coronary Artery Disease With Myocardial Insulin Resistance
Diabetes, October 1, 2002; 51(10): 3020 - 3024.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
G. P. Pappas, E. W. Olcott, and J. E. Drace
Imaging of skeletal muscle function using 18FDG PET: force production, activation, and metabolism
J Appl Physiol, January 1, 2001; 90(1): 329 - 337.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
T. Utriainen, S. Lovisatti, S. Makimattila, A. Bertoldo, S. Weintraub, R. DeFronzo, C. Cobelli, and H. Yki-Jarvinen
Direct measurement of the lumped constant for 2-deoxy-[1-14C]glucose in vivo in human skeletal muscle
Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E228 - E233.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Otani, Y. Kagaya, Y. Yamane, M. Chida, K. Ito, S. Namiuchi, N. Shiba, Y. Koseki, M. Ninomiya, J. Ikeda, et al.
Long-Term Right Ventricular Volume Overload Increases Myocardial Fluorodeoxyglucose Uptake in the Interventricular Septum in Patients With Atrial Septal Defect
Circulation, April 11, 2000; 101(14): 1686 - 1692.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. H. McNulty
Comparison of local and systemic effects of insulin on myocardial glucose extraction in ischemic heart disease
Am J Physiol Heart Circ Physiol, March 1, 2000; 278(3): H741 - H747.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. F. Kofoed, H. Schoder, R. J. Knight, and D. B. Buxton
Glucose metabolism in reperfused myocardium measured by [2-18F] 2-fluorodeoxyglucose and PET
Cardiovasc Res, January 14, 2000; 45(2): 321 - 329.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Laine, C. Katoh, M. Luotolahti, H. Yki-Jarvinen, I. Kantola, A. Jula, T. O. Takala, U. Ruotsalainen, H. Iida, M. Haaparanta, et al.
Myocardial Oxygen Consumption Is Unchanged but Efficiency Is Reduced in Patients With Essential Hypertension and Left Ventricular Hypertrophy
Circulation, December 14, 1999; 100(24): 2425 - 2430.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
H. Jadvar, H. W. Strauss, and G. M. Segall
SPECT and PET in the Evaluation of Coronary Artery Disease
RadioGraphics, July 1, 1999; 19(4): 915 - 926.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1998 by the Society of Nuclear Medicine.